Legal & General Group’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-19,109
Closed -$301K 3535
2022
Q2
$301K Buy
19,109
+1,056
+6% +$16.1K ﹤0.01% 2496
2022
Q1
$275K Buy
18,053
+924
+5% +$14.1K ﹤0.01% 2562
2021
Q4
$263K Hold
17,129
﹤0.01% 2605
2021
Q3
$149K Buy
17,129
+10,036
+141% +$91.5K ﹤0.01% 2763
2021
Q2
$72K Sell
7,093
-1,224
-15% -$12.9K ﹤0.01% 2839
2021
Q1
$100K Buy
8,317
+948
+13% +$10.7K ﹤0.01% 2621
2020
Q4
$67K Sell
7,369
-111
-1% -$859 ﹤0.01% 2721
2020
Q3
$46K Sell
7,480
-1,899
-20% -$14.5K ﹤0.01% 2726
2020
Q2
$84K Buy
9,379
+4,758
+103% +$41K ﹤0.01% 2579
2020
Q1
$34K Sell
4,621
-2,226
-33% -$16.5K ﹤0.01% 2733
2019
Q4
$60K Hold
6,847
﹤0.01% 2751
2019
Q3
$42K Buy
6,847
+1,176
+21% +$6.61K ﹤0.01% 2813
2019
Q2
$24K Hold
5,671
﹤0.01% 3137
2019
Q1
$36K Buy
5,671
+646
+13% +$4.53K ﹤0.01% 2845
2018
Q4
$33K Hold
5,025
﹤0.01% 2871
2018
Q3
$42K Hold
5,025
﹤0.01% 2868
2018
Q2
$31K Sell
5,025
-1,462
-23% -$9.3K ﹤0.01% 3012
2018
Q1
$44K Sell
6,487
-998
-13% -$6.34K ﹤0.01% 2819
2017
Q4
$49K Sell
7,485
-495
-6% -$3.02K ﹤0.01% 2872
2017
Q3
$45K Hold
7,980
﹤0.01% 2944
2017
Q2
$62K Hold
7,980
﹤0.01% 2845
2017
Q1
$71K Sell
7,980
-238
-3% -$2.48K ﹤0.01% 2733
2016
Q4
$89K Buy
8,218
+3,117
+61% +$41.6K ﹤0.01% 2632
2016
Q3
$84K Buy
5,101
+1,092
+27% +$15.4K ﹤0.01% 2294
2016
Q2
$37K Buy
+4,009
New +$43.6K ﹤0.01% 2628

Other funds holding NPTN

Legal & General Group's NPTN Position: Q3 2022 in Review

Legal & General Group sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 19,109 shares — an estimated $301K sold.

Legal & General Group first reported a position in NPTN in Q2 2016 and held it in 25 quarters. The position peaked at $301K in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Legal & General Group reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Legal & General Group sold 19,109 NEOPHOTONICS CORP shares in Q3 2022, an estimated $301K.
  • Legal & General Group first reported a position in NEOPHOTONICS CORP in Q2 2016 and held it in 25 quarters.
  • Legal & General Group's NEOPHOTONICS CORP position peaked at $301K in Q2 2022.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Legal & General Group's 13F filing for Q3 2022, filed 14 Nov 2022.